title: Bradyarrhythmias Associated with Sofosbuvir Treatment.
authors.forename: Hélène
authors.initials: H
authors.lastname: Fontaine
authors.forename: Arnaud
authors.initials: A
authors.lastname: Lazarus
authors.forename: Stanislas
authors.initials: S
authors.lastname: Pol
authors.forename: Caroline
authors.initials: C
authors.lastname: Pecriaux
authors.forename: François
authors.initials: F
authors.lastname: Bagate
authors.forename: Philippe
authors.initials: P
authors.lastname: Sultanik
authors.forename: Estelle
authors.initials: E
authors.lastname: Boueyre
authors.forename: Marion
authors.initials: M
authors.lastname: Corouge
authors.forename: Vincent
authors.initials: V
authors.lastname: Mallet
authors.forename: Anaïs
authors.initials: A
authors.lastname: Vallet-Pichard
authors.forename: Philippe
authors.initials: P
authors.lastname: Sogni
authors.forename: Denis
authors.initials: D
authors.lastname: Duboc
mesh_terms: D000368:Aged; D000638:Amiodarone / Q000009:adverse effects*; D000998:Antiviral Agents / Q000009:adverse effects*; D001919:Bradycardia / Q000139:chemically induced*; D004359:Drug Therapy, Combination / Q000009:adverse effects; D005260:Female; D019698:Hepatitis C, Chronic / Q000188:drug therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D000069474:Sofosbuvir; D014542:Uridine Monophosphate / Q000009:adverse effects / Q000031:analogs & derivatives*
chemical_list: D000998:Antiviral Agents; D014542:Uridine Monophosphate; D000638:Amiodarone; D000069474:Sofosbuvir